Research Output per year
Fingerprint Dive into the research topics where Laura Montefusco is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Acromegaly
Medicine & Life Sciences
Type 2 Diabetes Mellitus
Medicine & Life Sciences
Langerhans Cell Histiocytosis
Medicine & Life Sciences
Thyrotropin Alfa
Medicine & Life Sciences
Somatotropin Receptors
Medicine & Life Sciences
Phenotype
Medicine & Life Sciences
Glucose
Medicine & Life Sciences
Thyroid Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2009 2019
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study
Solini, A., Penno, G., Orsi, E., Bonora, E., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F., Lamacchia, O., Baroni, M. G., Nicolucci, A., Pugliese, G., Bollanti, L., Alessi, E., Vitale, M., Cirrito, T., Cavallo-Perin, P., Gruden, G., Lorenzati, B., Trovati, M. & 30 others, , Apr 25 2019, In : BMC Medicine. 17, 1, 83.Research output: Contribution to journal › Review article
Open Access
Type 2 Diabetes Mellitus
Cohort Studies
Prospective Studies
Hypertension
Mortality
4
Citations
(Scopus)
Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis
Montefusco, L., Harari, S., Elia, D., Rossi, A., Specchia, C., Torre, O., Adda, G. & Arosio, M., 2018, In : European Journal of Internal Medicine. 51, p. 61-67Research output: Contribution to journal › Article
Langerhans Cell Histiocytosis
Diabetes Insipidus
Lung
Glucose
Adrenal Insufficiency
4
Citations
(Scopus)
Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis
Montefusco, L., Harari, S., Elia, D., Rossi, A., Specchia, C., Torre, O., Adda, G. & Arosio, M., Nov 29 2017, In : European Journal of Internal Medicine.Research output: Contribution to journal › Article
Langerhans Cell Histiocytosis
Diabetes Insipidus
Lung
Glucose
Adrenal Insufficiency
11
Citations
(Scopus)
Use of Liraglutide in the Real World and Impact at 36 Months on Metabolic Control, Weight, Lipid Profile, Blood Pressure, Heart Rate, and Renal Function
Rondinelli, M., Rossi, A., Gandolfi, A., Saponaro, F., Bucciarelli, L., Adda, G., Molinari, C., Montefusco, L., Specchia, C., Chiara Rossi, M., Scardapane, M., Arosio, M. & Genovese, S., Jan 1 2017, In : Clinical Therapeutics. 39, 1, p. 159-169 11 p.Research output: Contribution to journal › Article
Heart Rate
Blood Pressure
Kidney
Lipids
Weights and Measures
11
Citations
(Scopus)
Improved diastolic function in type 2 diabetes after a six month liraglutide treatment
Saponaro, F., Sonaglioni, A., Rossi, A., Montefusco, L., Lombardo, M., Adda, G. & Arosio, M., Aug 1 2016, In : Diabetes Research and Clinical Practice. 118, p. 21-28 8 p.Research output: Contribution to journal › Article
Type 2 Diabetes Mellitus
Therapeutics
Control Groups
Hypoglycemic Agents
Observational Studies